Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

L Oreland

Showing results (81-90 of 255) with videos related to

Pageof 26
Sort By:
Biochemical Pharmacology|September 1, 1982
Some properties of monoamine oxidase and a semicarbazide sensitive amine oxidase capable of the deamination of 5-hydroxytryptamine from porcine dental pulpA Norqvist, L Oreland, C J Fowler
Life Sciences|December 14, 1981
Low platelet monoamine oxidase activity in cigarette smokersL Oreland, C J Fowler, D Schalling
Medical Biology|April 1, 1983
Platelet MAO activity in patients with chronic pain syndrome. Relationship to personality traits, endorphins in CSF and plasma cortisolF Johansson, L Von Knorring, L Oreland
European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology|June 1, 1995
Decreased methionine adenosyltransferase activity in erythrocytes of patients with dementia disordersC Gomes Trolin, B Regland, L Oreland
Perspectives in Biology and Medicine|January 1, 1984
Dopamine receptors and monoamine oxidase as virion receptorsE G Shaskan, L Oreland, G Wadell
Acta Pharmacologica Et Toxicologica|May 1, 1976
Biochemical and behavioural effects of thiothixene: relation to tissue levels of the drugT Mjörndal, F A Wiesel, L Oreland
European Archives of Psychiatry and Clinical Neuroscience|January 1, 1991
Vitamin B12-induced reduction of platelet monoamine oxidase activity in patients with dementia and pernicious anaemiaB Regland, C G Gottfries, L Oreland
Journal of Studies on Alcohol|March 1, 1996
Personality disorders according to DSM-III-R and thrombocyte monoamine oxidase activity in type 1 and type 2 alcoholicsJ Hallman, L von Knorring, L Oreland
Life Sciences|December 1, 1973
The mechanism of action of the monoamine oxidase inhibitor pargylineL Oreland, H Kinemuchi, B Y Yoo
Neuropeptides|February 26, 2000
Neuropeptide Y attenuates the effect of locus coeruleus denervation by DSP-4 treatment on social behaviour in the ratA Kask, M Eller, L Oreland, et al.
Pageof 26

Showing results (81-90 of 255) with videos related to

Sort By:
Pageof 26
Biochemical Pharmacology|September 1, 1982
Some properties of monoamine oxidase and a semicarbazide sensitive amine oxidase capable of the deamination of 5-hydroxytryptamine from porcine dental pulpA Norqvist, L Oreland, C J Fowler
Life Sciences|December 14, 1981
Low platelet monoamine oxidase activity in cigarette smokersL Oreland, C J Fowler, D Schalling
Medical Biology|April 1, 1983
Platelet MAO activity in patients with chronic pain syndrome. Relationship to personality traits, endorphins in CSF and plasma cortisolF Johansson, L Von Knorring, L Oreland
European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology|June 1, 1995
Decreased methionine adenosyltransferase activity in erythrocytes of patients with dementia disordersC Gomes Trolin, B Regland, L Oreland
Perspectives in Biology and Medicine|January 1, 1984
Dopamine receptors and monoamine oxidase as virion receptorsE G Shaskan, L Oreland, G Wadell
Acta Pharmacologica Et Toxicologica|May 1, 1976
Biochemical and behavioural effects of thiothixene: relation to tissue levels of the drugT Mjörndal, F A Wiesel, L Oreland
European Archives of Psychiatry and Clinical Neuroscience|January 1, 1991
Vitamin B12-induced reduction of platelet monoamine oxidase activity in patients with dementia and pernicious anaemiaB Regland, C G Gottfries, L Oreland
Journal of Studies on Alcohol|March 1, 1996
Personality disorders according to DSM-III-R and thrombocyte monoamine oxidase activity in type 1 and type 2 alcoholicsJ Hallman, L von Knorring, L Oreland
Life Sciences|December 1, 1973
The mechanism of action of the monoamine oxidase inhibitor pargylineL Oreland, H Kinemuchi, B Y Yoo
Neuropeptides|February 26, 2000
Neuropeptide Y attenuates the effect of locus coeruleus denervation by DSP-4 treatment on social behaviour in the ratA Kask, M Eller, L Oreland, et al.
Pageof 26